Literature DB >> 31000450

Increasing the Risk of Stroke by Opium Addiction.

Seyed Mohammad Mousavi-Mirzaei1, Abolfazl Talebi2, Alireza Amirabadizadeh1, Samaneh Nakhaee1, Ghodsieh Azarkar3, Omid Mehrpour4.   

Abstract

INTRODUCTION: Stroke is among the leading causes of mortality and morbidity in the world. Besides the identified risk factor, Ischemic stroke evidence show drug use develops or exacerbates the atherosclerotic process. The current study aimed at comparing cerebrovascular ultrasounds' changes in addicted and nonaddicted people who developed ischemic stroke.
METHODS: In the current cross-sectional study, a total of 133 patients with ischemic stroke who were admitted to Vali-Asr hospital from June 2016 to April 2017 were enrolled. For obtaining the quantitative data, t test or Mann-Whitney test was employed to compare the addict or no-addict groups, as well as, categorical data testing was performed using chi-square test. Also, the multiple logistic regression was used for identifying the factors and the significance level was set at 5%.
RESULTS: The current study was performed on 133 patients, among them 41 patients (30.8%) were opium addicted, and 92 patients (69.2%) were nonaddict. The mean [IQR] number of atherosclerotic plaques were significantly higher in opium addicted group in comparison with the nonaddicted group (3.0 [1.0-4.0] versus 1.5 [0.0-3.0], P = .008). The possibility of increasing the number of plaques in addicted patients was 1.42 times higher than the nonaddicted patients (odds ratio (95% confidence interval): 1.42 (1.11-1.81), P = .005).
CONCLUSION: The findings demonstrated a significant difference in the vessel stenosis pattern between the addict and nonaddict ischemic stroke groups. To investigate the possible effects of opium use and its associated parameters, ie, dosage, duration of use, and the way of opium use on ischemic stroke, further studies are required.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Stroke; addiction; cerebrovascular accident; opium

Mesh:

Year:  2019        PMID: 31000450     DOI: 10.1016/j.jstrokecerebrovasdis.2019.03.044

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  7 in total

Review 1.  Consequences of Opioid Abuse and their Treatments in Persian Medicine: A Review Study.

Authors:  Mohadese Kamali; Haleh Tajadini; Mehrzad Mehrabani; Masoud Moghadari
Journal:  Addict Health       Date:  2020-01

Review 2.  Opium and cardiovascular health: A devil or an angel?

Authors:  Pegah Roayaei; Arya Aminorroaya; Ali Vasheghani-Farahani; Alireza Oraii; Saeed Sadeghian; Hamidreza Poorhosseini; Farzad Masoudkabir
Journal:  Indian Heart J       Date:  2020-10-20

3.  Comparison of Brain Magnetic Resonance Imaging Lesions in Opium Addict and Non-addict Patients with Thrombotic Stroke: A Case-Control Study.

Authors:  Farhad Iranmanesh; Rostam Syfadini; Yaseman Mahalati; Faranak Gadari; Tania Dehesh
Journal:  Addict Health       Date:  2021-04

4.  Opium abuse and stroke in Iran: A systematic review and meta-analysis.

Authors:  Parham Mardi
Journal:  Front Neurol       Date:  2022-09-09       Impact factor: 4.086

5.  Cross-sectional study of passive opiate smoking in relation to stroke and some of stroke attributable risk factors in women.

Authors:  Nazanin Jalali; Parvin Khalili; Saeed Bahrampour; Mohammad Mahmoudabadi; Ali Esmaeili Nadimi; Zahra Jalali
Journal:  Sci Rep       Date:  2022-09-30       Impact factor: 4.996

Review 6.  Treatment of opium addiction in persian medicine: A review study.

Authors:  Mohadese Kamali; Hoda Kamali; Mohammadmahdi Doustmohammadi; Hojjat Sheikhbardsiri; Masoud Moghadari
Journal:  J Educ Health Promot       Date:  2021-05-20

7.  Predictive value of the sequential organ failure assessment (SOFA) score for prognosis in patients with severe acute ischemic stroke: a retrospective study.

Authors:  Wei Qin; Xiaoyu Zhang; Lei Yang; Yue Li; Shuna Yang; Xuanting Li; Wenli Hu
Journal:  J Int Med Res       Date:  2020-08       Impact factor: 1.671

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.